Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Fabio Ciceri and Lorenzo Dagna.
Fabio Ciceri
Connection Strength
3.297
Lorenzo Dagna
  1. Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation. Front Immunol. 2021; 12:675678.
    View in: PubMed
    Score: 0.236
  2. Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study. Lancet Rheumatol. 2021 Apr; 3(4):e253-e261.
    View in: PubMed
    Score: 0.232
  3. Targeting IL-1, IL-6 or GM-CSF in COVID-19. Response to: 'More evidences on which biologic and which pathway is key in severe-critical COVID-19 pneumonia' by Ferraccioli. Ann Rheum Dis. 2020 Jul 31.
    View in: PubMed
    Score: 0.224
  4. GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study. Lancet Rheumatol. 2020 Aug; 2(8):e465-e473.
    View in: PubMed
    Score: 0.222
  5. Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy. Clin Immunol. 2020 08; 217:108509.
    View in: PubMed
    Score: 0.222
  6. Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study. Eur J Intern Med. 2020 06; 76:43-49.
    View in: PubMed
    Score: 0.221
  7. Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study. Lancet Rheumatol. 2020 Jun; 2(6):e325-e331.
    View in: PubMed
    Score: 0.220
  8. Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis. Crit Care Resusc. 2020 04 15; 22(2):95-97.
    View in: PubMed
    Score: 0.219
  9. Effects of glucocorticoids on B-cell subpopulations in patients with IgG4-related disease. Clin Exp Rheumatol. 2019 May-Jun; 37 Suppl 118(3):159-166.
    View in: PubMed
    Score: 0.201
  10. Increase of circulating memory B cells after glucocorticoid-induced remission identifies patients at risk of IgG4-related disease relapse. Arthritis Res Ther. 2018 10 03; 20(1):222.
    View in: PubMed
    Score: 0.197
  11. Eosinophils from Physiology to Disease: A Comprehensive Review. Biomed Res Int. 2018; 2018:9095275.
    View in: PubMed
    Score: 0.188
  12. A virus-free cellular model recapitulates several features of severe COVID-19. Sci Rep. 2021 09 01; 11(1):17473.
    View in: PubMed
    Score: 0.060
  13. Testosterone in males with COVID-19: A 7-month cohort study. Andrology. 2022 01; 10(1):34-41.
    View in: PubMed
    Score: 0.060
  14. Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19. Sci Rep. 2021 May 17; 11(1):10699.
    View in: PubMed
    Score: 0.059
  15. Drug reaction with eosinophilia and systemic symptoms (DRESS) in patients with COVID-19. Clin Microbiol Infect. 2021 08; 27(8):1190-1192.
    View in: PubMed
    Score: 0.059
  16. Correction to: Can Cytokine Blocking Prevent Depression in COVID-19 Survivors? J Neuroimmune Pharmacol. 2021 Mar; 16(1):211.
    View in: PubMed
    Score: 0.058
  17. Pulmonary Vascular Thrombosis in COVID-19 Pneumonia. J Cardiothorac Vasc Anesth. 2021 Dec; 35(12):3631-3641.
    View in: PubMed
    Score: 0.058
  18. Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19. Sci Rep. 2020 12 04; 10(1):21291.
    View in: PubMed
    Score: 0.057
  19. Can Cytokine Blocking Prevent Depression in COVID-19 Survivors? J Neuroimmune Pharmacol. 2021 03; 16(1):1-3.
    View in: PubMed
    Score: 0.057
  20. Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors. Clin Microbiol Infect. 2021 Mar; 27(3):451-457.
    View in: PubMed
    Score: 0.057
  21. Biobanking for COVID-19 research. Panminerva Med. 2020 Oct 19.
    View in: PubMed
    Score: 0.057
  22. Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy. Crit Care Resusc. 2020 Sep; 22(3):200-211.
    View in: PubMed
    Score: 0.056
  23. Stranger Months: How SARS-CoV-2, Fear of Contagion, and Lockdown Measures Impacted Attendance and Clinical Activity During February and March 2020 at an Urban Emergency Department in Milan. Disaster Med Public Health Prep. 2021 10; 15(5):e33-e42.
    View in: PubMed
    Score: 0.056
  24. Prevalence, Characteristics, Risk Factors, and Outcomes of Invasively Ventilated COVID-19 Patients with Acute Kidney Injury and Renal Replacement Therapy. Blood Purif. 2021; 50(1):102-109.
    View in: PubMed
    Score: 0.056
  25. Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort study. Ann Rheum Dis. 2020 10; 79(10):1277-1285.
    View in: PubMed
    Score: 0.056
  26. Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy. Crit Care Resusc. 2020 Apr 23.
    View in: PubMed
    Score: 0.055
  27. Fast reshaping of intensive care unit facilities in a large metropolitan hospital in Milan, Italy: facing the COVID-19 pandemic emergency Crit Care Resusc. 2020 04 01; 22(2):91-94.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.